Biotech and Pharmaceuticals
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their first season of the virus, bringing to market a rival to a similar treatment from Sanofi and AstraZeneca. The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead […]
Read More
JPMorgan’s top biotech and pharma picks for the second half
Biopharmaceutical stocks’ underperformance versus the broader market for a third-straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm’s June outlook for biopharma that the sector’s poor performance can be traced back to concerns over President Donald Trump’s tariffs and his ” most favored nation ” executive order. […]
Read More
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I’m back in New […]
Read More
Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. A wave of outrage is sweeping the scientific and medical world after Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to stop recommending routine Covid-19 […]
Read More
CDC ends Covid vaccine recommendation for healthy kids and pregnant women
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and Secretary of Education Linda McMahon attend a Make America Healthy Again (MAHA) Commission event, in the East Room of the White House in Washington, D.C., U.S., May 22, 2025. Evelyn Hockstein | Reuters The Centers for Disease Control and Prevention will no longer […]
Read More
Founders of Amazon’s PillPack launch health-care marketplace startup General Medicine
General Medicine founders TJ Parker, Ashwin Muralidharan and Elliot Cohen. General Medicine After selling online pharmacy PillPack to Amazon seven years ago, the founding team is launching a new company that aims to make the experience of getting medical care “as easy as shopping online.” PillPack founders TJ Parker and Elliot Cohen on Thursday launched a […]
Read More
How UnitedHealthcare became the face of America’s health insurance frustrations
Flags fly at half staff outside the United Healthcare corporate headquarters in Minnetonka, Minnesota, Dec. 4, 2024. Stephen Maturen | Getty Images News | Getty Images It took six months, countless hours on hold and intervention from state regulators before Sue Cover says she finally resolved an over $1,000 billing dispute with UnitedHealthcare in 2023. […]
Read More
Healthy Returns: Novavax scores narrower Covid vaccine approval after delay
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight […]
Read More
FDA outlines stricter Covid vaccine booster approval standards for healthy people
Brandon Guerrero, 34, of Compton, receives both a flu and COVID-19 vaccine at CVS in Huntington Park on August 28, 2024. Christina House | Los Angeles Times | Getty Images The Food and Drug Administration on Tuesday outlined new regulatory guidance for future Covid-19 vaccine boosters, setting stricter approval standards for healthy Americans. The FDA […]
Read More
Novo Nordisk’s future in doubt after Wegovy maker’s ‘surprise’ CEO ouster
Novo Nordisk’s ousting of longtime CEO Lars Fruergaard Jørgensen bemused analysts, with many questioning the future of the Wegovy obesity drug maker. Source
Read More